These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30085153)

  • 1. Mixed Mycobacterium tuberculosis-Strain Infections Are Associated With Poor Treatment Outcomes Among Patients With Newly Diagnosed Tuberculosis, Independent of Pretreatment Heteroresistance.
    Shin SS; Modongo C; Baik Y; Allender C; Lemmer D; Colman RE; Engelthaler DM; Warren RM; Zetola NM
    J Infect Dis; 2018 Nov; 218(12):1974-1982. PubMed ID: 30085153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of
    Assis Figueredo LJ; de Almeida IN; Augusto CJ; Soares VM; Suffys PN; Carvalho WDS; de Miranda SS
    Int J Mycobacteriol; 2020; 9(4):368-372. PubMed ID: 33323651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Heteroresistance Mycobacterium Tuberculosis in Saudi Arabia.
    Abakur EHA; Alnour TMS; Abuduhier F; Albalawi FMA; Alfifi KAS
    Infect Disord Drug Targets; 2020; 20(4):491-494. PubMed ID: 30914036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A
    PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India.
    Tolani MP; D'souza DT; Mistry NF
    BMC Infect Dis; 2012 Jan; 12():9. PubMed ID: 22260344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
    Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
    Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment.
    Nimmo C; Brien K; Millard J; Grant AD; Padayatchi N; Pym AS; O'Donnell M; Goldstein R; Breuer J; Balloux F
    EBioMedicine; 2020 May; 55():102747. PubMed ID: 32361247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates.
    Zheng C; Li S; Luo Z; Pi R; Sun H; He Q; Tang K; Luo M; Li Y; Couvin D; Rastogi N; Sun Q
    J Clin Microbiol; 2015 Jul; 53(7):2138-47. PubMed ID: 25903578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
    Eilertson B; Maruri F; Blackman A; Herrera M; Samuels DC; Sterling TR
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3270-5. PubMed ID: 24687490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests.
    Zetola NM; Modongo C; Moonan PK; Ncube R; Matlhagela K; Sepako E; Collman RG; Bisson GP
    J Infect Dis; 2014 Jun; 209(11):1754-63. PubMed ID: 24443546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis.
    Kabir S; Junaid K; Rehman A
    Int J Infect Dis; 2021 Feb; 103():56-61. PubMed ID: 33181327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia.
    Mekonnen D; Admassu A; Mulu W; Amor A; Benito A; Gelaye W; Biadglegne F; Abera B
    Int J Infect Dis; 2015 Oct; 39():34-8. PubMed ID: 26119857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India.
    Gupta R; Thakur R; Kushwaha S; Jalan N; Rawat P; Gupta P; Aggarwal A; Gupta M; Manchanda V
    Indian J Tuberc; 2018 Jan; 65(1):52-56. PubMed ID: 29332649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India.
    Desikan P; Panwalkar N; Punde RP; Khan Z; Pauranik A; Mirza SB; Chourey M; Anand S; Sachdeva KS
    Indian J Med Res; 2023; 157(2&3):174-182. PubMed ID: 37202936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
    Hung NV; Ando H; Thuy TT; Kuwahara T; Hang NT; Sakurada S; Thuong PH; Lien LT; Keicho N
    BMC Res Notes; 2013 Nov; 6():444. PubMed ID: 24188178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.
    Hofmann-Thiel S; van Ingen J; Feldmann K; Turaev L; Uzakova GT; Murmusaeva G; van Soolingen D; Hoffmann H
    Eur Respir J; 2009 Feb; 33(2):368-74. PubMed ID: 18829680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan.
    Farooqi JQ; Khan E; Alam SM; Ali A; Hasan Z; Hasan R
    J Pak Med Assoc; 2012 Aug; 62(8):767-72. PubMed ID: 23862246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China.
    Zhang J; Mi L; Wang Y; Liu P; Liang H; Huang Y; Lv B; Yuan L
    BMC Res Notes; 2012 Jun; 5():309. PubMed ID: 22713520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria.
    Bouziane F; Allem R; Sebaihia M; Kumanski S; Mougari F; Sougakoff W; Raskine L; Yala D; Cambau E;
    J Glob Antimicrob Resist; 2019 Dec; 19():301-307. PubMed ID: 31100498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features?
    Escalante P; McKean-Cowdin R; Ramaswamy SV; Williams-Bouyer N; Teeter LD; Jones BE; Graviss EA
    Int J Tuberc Lung Dis; 2013 May; 17(5):644-51. PubMed ID: 23453008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.